SkinDermic
Entity

  • SkinDermic

    Created in 2017
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    253

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    24 Rue du Faubourg Saint-Jacques, 75014 Paris, France

    Paris

    France

  • Employees

    Scale: 2-10

    Estimated: 5

  • SIREN

    828832139

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    1 year, 3 months ago
Description
  • Value proposition

    Clinical stage biotech company with innovative first-in-class new treatments in virology and dermatology

    SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of HHV8 virus linked neoplasia and inflammatory skin diseases.

    SkinDermic® recently completed proof of concept clinical phase in humans with its First-in-Class treatments for acne and HHV8 associated diseases (Kaposi Sarcoma and Lymphomas).
    Skindermic owns now a pipeline with very active and very well tolerated new drugs for HHV8 associated diseases and acne vulgaris.

  • Original language

    Clinical stage biotech company with innovative first-in-class new treatments in virology and dermatology

    SkinDermic est une biotech spécialisée dans la recherche de médicaments pour le traitements des réactions infectieuses et inflammatoires de la peau.

Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics